Aunque el mecanismo de accin no es completamente conocido, pudiendo verse implicados mecanismos relacionados con los receptores de GLP-1 y GIP, los resultados iniciales muestran perspectivas alentadoras en el tratamiento de la obesidad
That's what I'm doing." He admits, however, that he still struggles sometimes
Clinical trials show average weight loss of 24 kg over 48 weeks at the lowest dose, though individual results vary widely based on metabolic factors, adherence, and lifestyle
In the original mouse work it was described as well-tolerated, but that is the limit of the in-vivo safety evidence, and it is mouse-only
The severity depends partly on your geneticsspecific genetic variants in the GIPR pathways influence how sensitive your receptors are to the medication, which is why two people on the same dose experience vastly different side effect profiles
At 12 mg, the relative risk was 2.04, with a confidence interval of 1.06 to 3.94 and a P value of 0.03